This is a limited company view. Sign up for a Free Trial to see everything.

Stentys offers simple, innovative solutions to international cardiologists when treating the challenging disease of their patients. When faced with a situation where choosing the appropriate stent size is not easy, such as in acute myocardial infarction or in bifurcation lesions, the STENTYS platform provides an efficient and elegant new treatment approach. The STENTYS stent can cater for a range of vessel diameters and is able to adapt itself acutely to different diameters along the vessel. It can also continue to expand over time to remain apposed to the vessel, even when there is positive remodelling.

B2B
Biotechnology
Hardware
Healthcare
Medical Devices
Pharmaceuticals

Overview

Location

Paris

Founded

2006

Employees

34

Stage

Series B

Total funding

$40M

Last funding

9 years ago

Acquisitions

0

Growth score

3

Mindshare score

3

Scoring

Deals

Employee Growth

Use Stentys's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Stentys's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Chief Technology Officer
Marketing Director
Business Development Manager- Middle East/Africa (MEA)
Market Development Manager Italy
Country Manager Italy
Country Manager France
Country Manager
Country Manager Germany
Director of Regulatory Affairs
Principal Technician Lab Manager
Independent Director
Area Sales Manager
Ingénieur R&D
Quality Specialist
Sales Director International
Responsable administratif et financier

Similar Companies

Tensha Therapeutics

As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Series A|1 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes